Orkla Care A/S
CVR: 16173592
Secondary names: VITALIA A/S, NUTRICARE A/S, DROGEN'S PHARMA A/S
Orkla Care A/S demonstrates a solid financial health with a consistent upward trend in revenue and profit over the past few years. In 2024, the company reported revenue of 865.4 million DKK and a profit of 103.1 million DKK, marking an increase from 837.5 million DKK in revenue and 94.9 million DKK in profit in 2023. Despite a decline in equity from 362.5 million DKK in 2023 to 280.6 million DKK in 2024, the company maintains a healthy profit margin and has shown resilience in its operations within the food manufacturing sector. Key concerns include the significant drop in equity, which may impact future investment capacity, but overall, Orkla Care A/S is well-positioned in its industry with a growing revenue base.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive handel og industri.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 865.4 mio. | 103.1 mio. | 892.6 mio. | 280.6 mio. | 233 | |
History
Ownership
Properties
(2)· 7 historic2 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Production units (8)
Similar companies
Companies in the same industry and area